Clinical Trials Directory

Trials / Completed

CompletedNCT04850534

Systemic Inflammation in Liver Cirrhosis

Evaluation and Prognostic Indications of Systemic Inflammation in Liver Cirrhosis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Investigate systemic inflammation in liver cirrhosis patients

Conditions

Timeline

Start date
2019-04-01
Primary completion
2022-12-31
Completion
2023-10-30
First posted
2021-04-20
Last updated
2023-12-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04850534. Inclusion in this directory is not an endorsement.

Systemic Inflammation in Liver Cirrhosis (NCT04850534) · Clinical Trials Directory